From: Kidney function decline associated with proton pump inhibitors: results from the ELSA-Brasil cohort
Characteristics | Does not use PPI (N = 12,296) % or average (SD) | Use PPI (N = 1,005) % or average (SD) | Total (N = 13,301) % or average (SD) |
---|---|---|---|
eGFR (baseline) | 87.2 (13.5) | 84.9 (14.0)* | 87 (13.6) |
eGFR (Wave 2) | 84 (13.7) | 81.4 (13.9)* | 83.8 (13.7) |
Incident CKD (Wave 2)a | 3.6 | 6.5* | 3.8 |